Search research articles
Contact Us
Filters
Showing results (51-60 of 123) with videos related to
Page
of 13
Sort By:
The British Journal of Ophthalmology
|
February 11, 2022
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review
Aisha A Mumtaz, Andrew Fischer, Forat Lutfi, et al.
Blood Advances
|
December 23, 2021
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
Saurabh Dahiya, Tim Luetkens, Forat Lutfi, et al.
Blood
|
July 18, 2025
RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT
Zachariah DeFilipp, Hannah K Choe, Yvonne A Efebera, et al.
Cytotherapy
|
February 10, 2024
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products
Djordje Atanackovic, Thierry Iraguha, Destiny Omili, et al.
Acta Haematologica
|
August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation
Gabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 2, 2024
Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial
Rawad A Yared, Chieh-Chang Chen, Astrid Vandorpe, et al.
British Journal of Haematology
|
March 4, 2020
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy
Narendranath Epperla, Ang Li, Brent Logan, et al.
Neuro-Oncology
|
August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
Noa G Holtzman, Hao Xie, Soren Bentzen, et al.
Human Vaccines & Immunotherapeutics
|
June 6, 2023
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
Kathryn Kline, Wengen Chen, Michael E Kallen, et al.
Cancer Immunology, Immunotherapy : CII
|
February 13, 2024
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
Kathryn Kline, Tim Luetkens, Rima Koka, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 123) with videos related to
Sort By:
Page
of 13
The British Journal of Ophthalmology
|
February 11, 2022
Ocular adverse events associated with chimeric antigen receptor T-cell therapy: a case series and review
Aisha A Mumtaz, Andrew Fischer, Forat Lutfi, et al.
Blood Advances
|
December 23, 2021
Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapy
Saurabh Dahiya, Tim Luetkens, Forat Lutfi, et al.
Blood
|
July 18, 2025
RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease Following Allogeneic HCT
Zachariah DeFilipp, Hannah K Choe, Yvonne A Efebera, et al.
Cytotherapy
|
February 10, 2024
A novel multicolor fluorescent spot assay for the functional assessment of chimeric antigen receptor (CAR) T-cell products
Djordje Atanackovic, Thierry Iraguha, Destiny Omili, et al.
Acta Haematologica
|
August 27, 2024
Outcomes of Patients with Myeloid Malignancies and Cardiovascular Disease Undergoing Allogeneic Stem Cell Transplantation
Gabriela Sanchez-Petitto, Olga Goloubeva, James Childress, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
March 2, 2024
Intravenous Hemin, a potential heme oxygenase-1 activator, does not protect from post-ERCP acute pancreatitis in humans: Results of a randomized multicentric multinational placebo-controlled trial
Rawad A Yared, Chieh-Chang Chen, Astrid Vandorpe, et al.
British Journal of Haematology
|
March 4, 2020
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy
Narendranath Epperla, Ang Li, Brent Logan, et al.
Neuro-Oncology
|
August 5, 2020
Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
Noa G Holtzman, Hao Xie, Soren Bentzen, et al.
Human Vaccines & Immunotherapeutics
|
June 6, 2023
Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
Kathryn Kline, Wengen Chen, Michael E Kallen, et al.
Cancer Immunology, Immunotherapy : CII
|
February 13, 2024
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells
Kathryn Kline, Tim Luetkens, Rima Koka, et al.
Page
of 13